Extrinsic and intrinsic regulation of early natural killer cell development

Immunologic Research

Volumn 40, Issue 3, 2008, Pages 193-207

  Boos, Markus D ^a   Ramirez, Kevin ^a   Kee, Barbara L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cytokines; Lineage commitment; NK cells; Stromal cell; Transcription factors

Indexed keywords

HELIX LOOP HELIX PROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR;

BONE MARROW; CELL INTERACTION; CELL LINEAGE; CELL MATURATION; NATURAL KILLER CELL; ONTOGENY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STROMA CELL; THYMUS;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CELL LINEAGE; CYTOKINES; HELIX-LOOP-HELIX MOTIFS; HUMANS; KILLER CELLS, NATURAL; LYMPH NODES; RECEPTORS, CYTOKINE; THYMUS GLAND; TRANSCRIPTION FACTORS;

EID: 46149120087     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-007-8006-9     Document Type: Review

References (115)

1. Lanier LL. NK cell recognition. Ann Rev Immunol 2005;23:225-74.
2. Yokoyama WM. Natural killer cell immune responses. Immunol Rev 2005;32:317-25.
3. Orange JS. Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol 2006;6:399-409.
4. Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res 1999;23:615-24.
5. Suzuki R, Suzumiya J, Nakamura S, et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 2004;18:763-70.
6. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997;91:661-72.
7. Kouro T, Kumar V, Kincade PW. Relationships between early B- and NK-lineage lymphocyte precursors in bone marrow. Blood 2002;100:3672-80.
8. Welner RS, Pelayo R, Garrett KP, et al. Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors. Blood 2007;109:4825-931.
9. DiSanto JP, Vosshenrich CA. Bone marrow versus thymic pathways of natural killer cell development. Immunol Rev 2006;214:35-46.
10. Nutt SL, Kee BL. The transcriptional regulation of B-cell lineage commitment. Immunity 2007;26:715-25.
11. Rothenberg EV. Negotiation of the T lineage fate decision by transcription-factor interplay and microenvironmental signals. Immunity 2007;26:690-702.
12. Singh H, Medina KL, Pongubala JM. Contingen gene regulatory networks and B cell fate specification. Proc Natl Acad Sci USA 2005;102:4949-53.
13. DiSanto JP. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol 2006;24:257-86.
14. Yokoyama WM, Kim S, French AR. The dynamic life of natural killer cells. Ann Rev Immunol 2004;22:405-29.
15. Freud AG, Yokohama A, Becknell B, et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med 2006;203:1033-43.
16. Adolfsson J, Borge OJ, Bryder D, et al. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 2001;15:659-69.
17. Adolfsson J, Mansson R, Buza-Vidas N, et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential: a revised road map for adult blood lineage commitment. Cell 2005;121:295-306.
18. Kim S, Iizuka K, Kang HS, et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002;3:523-28.
19. Rosmaraki EE, Douagi I, Roth C, et al. Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol 2001;31:1900-9.
20. Vosshenrich CA, Ranson T, Samson SI, et al. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 2005;174:1213-21.
21. McNerney ME, Kumar V. The CD2 family of natural killer cell receptors. Curr Top Microbiol Immunol 2006;298:91-120.
22. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003;3:781-90.
23. Taniguchi RT, Guzior D, Kumar V. 2B4 inhibits NK cell fratricide. Blood 2007;110:2020-3.
24. Rouhi A, Gagnier L, Takei F, et al. Evidence for epigenetic maintenance of Ly49a monoallelic gene expression. J Immunol 2006;176:2991-9.
25. Tanamachi DM, Moniot DC, Cado D, et al. Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element. J Immunol 2004;172:1074-82.
26. Saleh A, Davies GE, Pascal V, et al. Identification of probabilistic transcriptional switches in the L49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 2004;21:55-66.
27. Yokoyama WM, Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 2006;214:143-54.
28. Takeda K, Cretney E, Hayakawa Y, et al. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 2005;105:2082-89.
29. Zamai L, Ahmad M, Bennett IM, et al. Natural killer (NK) cell-mediated cytotoxicity:differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 1998;188:2375-80.
30. Samson SI, Richard O, Tavian M, et al. Gata-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity 2003;19:701-11.
31. Vosshenrich CA, Garcia-Ojeda ME, Samson-Villeger SI, et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol 2006;7:1217-24.
32. Stewart CA, Xalzer T, Robbins SH, et al. Germ-line and rearranged Tcrd transcription distinguish bona fide NK cells and NK-like gammadelta T cells. Eur J Immunol 2007;37:1442-52.
33. Freud AG, Caligiuri MA. Human natural killer cell development. Immunol Rev 2006;214:56-72.
34. Allman D, Sambandam A, Kim S, et al. Thymopoiesis independent of common lymphoid progenitors. Nat Immunol 2003;4:168-74.
35. Schmitt TM, Ciofani M, Petrie HT, et al. Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med 2004;200:469-79.
36. Godin I, Cumano A. The hare and the tortoise: an embryonic haematopoietic race. Nat Rev Immunol 2002;2:166-71.
37. Carlyle JR, Zuniga-Pflucker JC. Lineage commiment and differentiation of T and natural killer lymphocytes in the fetal mouse. Immunol Rev 1998;165:63-74.
38. Rodewald H-R, Moingeon P, Lucich JL, et al. A population of early fetal thymocytes expressing FcγRII/III contains precursors of T lymphocytes and natural killer cells. Cell 1992;69:139-50.
39. Ikawa T, Kawamoto H, Fujimoto S, et al. Commitment of common T/Natural killer (NK) progenitors to unipotent T and NK progenitors in the murine fetal thymus revealed by a single progenitor assay. J Exp Med 1999;190:1617-27.
40. Carlyle JR, Michie AM, Cho SK, et al. Natural killer cell development and function precede alpha beta T cell differentiation in mouse fetal thymic ontogeny. J Immunol 1998;160:744-53.
41. Carlyle JR, Zunig-Pflucker JC. Regulation of NK1.1 expression during lineage commitment of progenitor thymocytes. J Immunol 1998;161:6544-51.
42. Rodewald H-R, Kretzschmar K, Takeda S, et al. Identification of pro-thymocytes in murine fetal blood: T lineage commitment can precede thymus colonization. EMBO J 1994;13:4229-40.
43. Carlyle JR, Mitchie AM, Furlonger C, et al. Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J Exp Med 1997;186:173-82.
44. Carlyle JR, Zunig-Pflucker JC. Requirement for the thymus in alpha beta T lymphocyte lineage commitment. Immunity 1998;9:187-97.
45. Douagi I, Colucci F, DiSanto JP, et al. Identification of the earliest prethymic bipotent T/NK progenitor in murine fetal liver. Blood 2002;99:463-71.
46. Sivakumar PV, Bennett M, Kumar V. Fetal and neonatal NK1.1+ Ly-49- cells can distinguish between major histocompatibility complex class I(hi) and classI(lo) target cells: evidence for a Ly-49-independent negative signaling receptor. Eur J Immunol 1997;27:3100-4.
47. Sivakumar PV, Gunturi A, Salcedo M, et al. Expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development. J Immunol 1999;162:6976-80.
48. Haller O, Wigzell H. Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent. J Immunol 1977;118:1503-6.
49. Kumar V, Ben-Ezra J, Bennett M, et al. Natural killer cells in mice treated with 89strontium:normal target-binding cell numbers but inability to kill even after interferon administration. J Immunol 1979;123:1832-8.
50. Puzanov IJ, Bennett M, Kumar V. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J Immunol 1996;157:4282-5.
51. Williams ND, Moore TA, Schatzle JD, et al. Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stromal-free culture: definition of cytokine requirements and developmental intermediates. J Exp Med 1997;186:1609-14.
52. Williams NS, Klem J, Puzanov IJ, et al. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitors. J Immunol 1999;163:2648-56.
53. Yu H, Fehniger TA, Fuchshuber P, et al. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood 1998;92:3647-57.
54. Zhang X, Sun S, Hwang I, et al. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 1998;8:591- 9vuctured>
55. Lodolce JP, Boone DL, Chai S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998;9:669-76.
56. Kennedy MK, Park LS. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J Clin Immunol 1996;16:134-43.
57. Dubois S, Mariner J, Waldmann TA, et al. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity 2002;17:537-47.
58. Burkett PR, Koka R, Chien M, et al. Coordinate expression and trans presentation of interleukin IL-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J Exp Med 2004;200:825-34.
59. Williams NS, Klem J, Puzanov IJ, et al. Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems. Immunol Rev 1998;165:47-61.
60. Sitnicka E, Bryder D, Theilgaard-Monch K, et al. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 2002;17:463-72.
61. Waskow C, Paul S, Haller C, et al. Viable c-Kit (W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis. Immunity 2002;17:277-88.
62. Reilly JT. Receptor tyrosine kinases in normal and malignant haematopoiesis. Blood Rev 2003;17:241-8.
63. Scheijen B, Griffin JD. Tryosine kinase oncogenes in normal hematopoiesis and hematological disease. Oncogene 2002;21:3314-33.
64. Colucci F, DiSanto JP. The receptor tyrosine kinase c-kit provides a critical singal for survival, expansion, and maturation of mouse natural killer cells. Blood 2000;95:984-91.
65. McKenna HJ, Stocking KL, Miller RE, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000;95:3489-97.
66. Cosman D. The hematopoietin receptor superfamily. Cytokine 1993;5:95-206.
67. Kee BL, Bain G, Murre C. IL7Ra and E47: independent pathways required for the development of multipotent lymphoid progenitors. EMBO J 2002;21:103-13.
68. Roth C, Rothlin C, Riou S, et al. Stromal-cell regulation of natural killer cell differentiation. J Mol Med 2007; in press.
69. Ciofani M, Zuniga-Pflucker JC. The thymus as an inductive site for T lymphopoiesis. Annu Rev Cell Dev Biol 2006; in press.
70. Pear WS, Radtke F. Notch signaling in lymphopoiesis. Semin Immunol 2003;15:69-79.
71. DeHart SL, Heikens MJ, Tsai S. Jagged2 promotes the development of natural killer cells and the establishment of functional natural killer cell lines. Blood 2005;105:3521-7.
72. Jaleco AC, Neves H, Hooijberg E, et al. Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J Exp Med 2001;194:991-1002.
73. Lehar SM, Dooley J, Farr AG, et al. Notch ligands Delta1 and Jagged1 transmit distinct signals to T-cell precursors. Blood 2005;105:1440-7.
74. Schmitt TM, Zuniga-Pflucker JC. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 2002;17:749-56.
75. Carotta S, Brady J, Wu L, et al. Transient Notch signaling induces NK cell potential in Pax5-deficient pro-B cells. Eur J Immunol 2006;36:3294-304.
76. Rolink AG, Balciunaite G, Demoliere C, et al. The potential involvement of Notch signaling in NK cell development. Immunol Lett 2006;107:50-7.
77. Yang LT, Nichols JT, Yao C, et al. Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1. Mol Biol Cell 2005;16:927-42.
78. Norris PS, Ware CF. The LT beta R signaling pathway. Adv Exp Med Biol 2007;597:160-72.
79. Iizuka K, Chaplin DD, Wang Y, et al. Requirement for membrane lymphotoxin in natural killer cell development. Proc Natl Acad Sci USA 1999;96:6336-40.
80. Wu Q, Sun Y, Wang J, et al. Signal via lymphotoxin-beta R on bone marrow stromal cells is required for an early checkpoint of NK cell development. J Immunol 2001;166:1684-9.
81. Lian RH, Chin RK, Nemeth HE, et al. A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development. Eur J Immunol 2004;34:2699-707.
82. Dittmer J. The biology of the Ets1 proto-oncogene. Mol Cancer 2003;10:1-29.
83. Barton K, Muthusamy N, Fischer C, et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 1998;9:555-63.
84. Ye SK, Kim TJ, Won SS, et al. Transcriptional regulation of the mouse interleukin-2 receptor beta chain gene by Ets and Erg-1. Biochem Biophys Res Commun 2005;329:1094-101.
85. Grund EM, Spyropoulos DD, Watson DK, et al. Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells. J Biol Chem 2005;280:4772-8.
86. Foulds CE, Nelson ML, Blaszczak AG, et al. Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol Cell Biol 2004;24:10954-64.
87. Boos MD, Eberl G, Yokota Y, et al. Mature natural killer cell and lymphid tissue inducing cell development requires Id2-mediated suppression of E-protein activity. J Exp Med 2007;204:1119-30.
88. DeKoter RP, Lee HJ, Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 2002;16:297-309.
89. Medina KL, Pongubala JM, Reddy KL, et al. Assembling a gene regulatory network for specification of the B cell fate. Dev Cell 2004;7:607-17.
90. Colucci F, Samson SI, DeKoter RP, et al. Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood 2001;97:2625-32.
91. Lacorazza HD, Miyazaki Y, Di Cristofano A, et al. The ETS protein MEF plays a critical role in perforin gene expression and development of natural killer and NK-T cells. Immunity 2002;17:437-49.
92. Townsend MJ, Weinmann AS, Matsuda JL, et al. T-bet regulates the terminal maturation and homeostasis of NK and V alpha14i NKT cells. Immunity 2004;20:477-94.
93. Szabo SJ, Kim ST, Costa GL, et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000;100:655-69.
94. Mullen AC, High FA, Hutchins AS, et al. Role of T-bet in commitment of TH1 cells before IL-12 dependent selection. Science 2001;292:1907-10.
95. Hwang ES, Szabo SJ, Schwartzberg PL, et al. T helper cell fate specified by kinase-mediated interaction of T-bet with Gata3. Science 2005;307:430-3.
96. Usui T, Preiss, Jc, Kanno Y, et al. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J Exp Med 2006;203:755-66.
97. Intlekofer AM, Takemoto N, Wherry EJ, et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol 2005;6:1236-44.
98. Lohoff M, Duncan GS, Ferrick D, et al. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J Exp Med 2000;192:325-36.
99. Taki S, Nakajima S, Ichikawa E, et al. IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells. J Immunol 2005;174:6005-12.
100. Kee BL, Helix-loop-helix proteins in lymphocyte lineage determination. In: Singh H, Grosschedl R, editors. CTMI. Molecular analysis of B lymphocyte development and activation. Springer-verlag; 2005. p. 15-27.
101. Sun X-H, Copeland NG, Jenkins NA, et al. Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol 1991;11:5603-11.
102. Massari ME, Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 2000;20:429-40.
103. Stinson J, Inoue T, Yates P, et al. Regulation of TCF ETS-domain transcription factors by helix-loop-helix motifs. Nucleic Acids Res 2003;31:4717-28.
104. Yates PR, Atherton GT, Deed RW, et al. Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors. Embo J 1999;18:968-76.
105. Lasorella A, Noseda M, Beyna M, et al. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 2000;407:592-8.
106. Sigvardsson M, O'Riordan M, Grosschedl R. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 1997;7:25-36.
107. Seet CS, Brumbaugh RL, Kee BL. Early B-cell factor promotes B-lymphopoiesis with reduced interleukin-7-responsiveness in the absence of E2A. J Exp Med 2004;199:1689-700.
108. Cobaleda C, Schebesta A, Delogu A, et al. Pax5: the guardian of B cell identity and function. Nat Immunol 2007;8:463-70.
109. Roessler S, Gyory I, Imhof S, et al. Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5. Mol Cell Biol 2007;27:579-94.
110. Schebesta A, McManus S, Salvagiotto G, et al. Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function. Immunity 2007;27:49-63.
111. Heemskerk MHM, Blom B, Nolan G, et al. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J Exp Med 1997;186:1597-602.
112. Bain G, Cravatt CB, Loomans C, et al. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nature Immunol 2001;2:165-71.
113. Anderson MK. At the crossroads: diverse roles of early thymocyte transcriptional regulators. Immunol Rev 2006;209:191-211.
114. Yokota Y, Mansouri A, Mori S, et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 1999;397:702-6.
115. Ikawa T, Fujimoto S, Kawamoto H, et al. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc Natl Acad Sci 2001;98:5164-9.